Application of nanoparticles in oral delivery of immediate release formulations

Current Nanoscience

Volumn 3, Issue 2, 2007, Pages 183-190

  Kesisoglou, Filippos ^a   Panmai, Santipharp ^a   Wu, Yunhui ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Bioavailability; Dissolution; Formulation; Nanoemulsions; Nanoparticles; Nanosuspensions

Indexed keywords

DISSOLUTION; EMULSIONS; HYDROPHOBICITY; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; SURFACE ACTIVE AGENTS;

ACTIVE PHARMACEUTICAL INGREDIENT; BIOAVAILABILITY; NANOSUSPENSIONS; SOLID LIPID NANOPARTICLES;

DRUG DELIVERY;

1 [4 (5 BROMO 2 PYRIMIDINYLOXY) 3 CHLOROPHENYL] 3 (2 NITROBENZOYL)UREA; AMPHOTERICIN B; APREPITANT; CAMPTOTHECIN; CARBENDAZIM; CILOSTAZOL; CLOZAPINE; CYCLOSPORIN; CYCLOSPORIN A; DANAZOL; FENOFIBRATE; GLYCEROL BEHENATE; IBUPROFEN; MACROGOL 400; MEGESTROL ACETATE; NANOCRYSTAL; NANOPARTICLE; NAPROXEN; NIFEDIPINE; PHOSPHATIDYLCHOLINE; POLOXAMER; POLYSORBATE 80; RAPAMYCIN; RETINOIC ACID; RICINOMACROGOL; SOLID LIPID NANOPARTICLE; SPIRONOLACTONE; SURFACTANT; UNINDEXED DRUG; VINPOCETINE;

CONTROLLED RELEASE FORMULATION; DISSOLUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; IN VITRO STUDY; IN VIVO STUDY; MICROCRYSTALLINE SUSPENSION; MICROEMULSION; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 34249790272     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341307780619251     Document Type: Review

References (64)

1. Yu, L.X.; Amidon, G.L.; Polli, J.E.; Zhao, H.; Mehta, M.U.; Conner, D.P.; Shah, V.P.; Lesko, L.J.; Chen, M.L.; Lee, V.H.; Hussain, A.S. Pharm. Res., 2002, 19, 921.
2. Wu, C.Y.; Benet, L.Z. Pharm. Res., 2005, 22, 11.
3. Noyes, A.; Whitney, W. J. Am. Chem. Soc., 1897, 19, 930.
4. Patravale, V.B.; Date, A.A.; Kulkami, R.M. J. Pharm. Pharmacol., 2004, 56, 827.
5. Mosharraf, M.; Nystrom, C. Int. J. Pharm., 1995, 122, 35.
6. Muller, R.H.; Peters, K. Int. J. Pharm., 1998, 160, 229.
7. Hu, J.; Johnston, K.P.; Williams, R.O. 3rd. Drug Dev. Ind. Pharm., 2004, 30, 233.
8. Muller, R.H.; Jacobs, C.; Kayser, O. Adv. Drug Deliv. Rev., 2001, 47, 3.
9. Rabinow, B.E. Nat. Rev. Drug. Discov., 2004, 3, 785.
10. Merisko-Liversidge, E.; Liversidge, G.G.; Cooper, E.R. Eur. J. Pharm. Sci., 2003, 18, 113.
11. Liversidge, G.G.; Cundy, K.C.; Bishop, J.F.; Czekai, D.A. US Patent 5,145,684, 1992.
12. Krause, K.P.; Muller, R.H. Int. J. Pharm., 2001, 214, 21.
13. Muller, R.H.; Becker, R.; Kruss, B.; Peters, K. US Patent 5,858,410, 1999.
14. Pathak, P.; Meziani, M.J.; Desai, T.; Sun, Y.P. J. Am. Chem. Soc., 2004, 126, 10842.
15. Pace, G.W.; Vachon, M.G.; Mishra, A.K.; I.B., H.; Krukonis, B. US Patent 6,177,103, 2001.
16. Hu, J.; Rogers, T.L.; Brown, J.; Young, T.; Johnston, K.P.; Williams, R.O., 3rd. Pharm. Res., 2002, 19, 1278.
17. Hu, J.; Johnston, K.P.; Williams, R.O., 3rd. Eur. J. Pharm. Sci., 2003, 20, 295.
18. Sarkari, M.; Brown, J.; Chen, X.; Swinnea, S.; Williams, R.O., 3rd; Johnston, K.P. Int. J. Pharm., 2002, 243, 17.
19. Kondo, N.; Iwao, T.; Kikuchi, M.; Shu, H.; Yamanouchi, K.; Yokoyama, K.; Ohyama, K.; Ogyu, S. Biol. Pharm. Bull., 1993, 16, 796.
20. Kondo, N.; Iwao, T.; Masuda, H.; Yamanouchi K.; Ishihara, Y.; Yamada, N.; Haga, T.; Ogawa., Y.; Yokoyama, K. Chem. Pharm. Bull. (Tokyo), 1993, 41, 737.
21. Liversidge, G.G.; Cundy, K.C. Int. J. Pharm., 1995, 125, 91.
22. Liversidge, G.G.; Conzentino, P. Int. J. Pharm., 1995, 125, 309.
23. Jinno, J.; Kamada, N.; Miyake, M.; Yamada, K.; Mukai, T.; Odomi, M.; Toguchi, H.; Liversidge, G.G.; Higaki, K.; Kimura, T. J. Control. Release, 2006, 111, 56.
24. Jia, L.; Wong, H.; Wang, Y.; Garza, M.; Weitman, S.D. J. Pharm. Sci., 2003, 92, 161.
25. Jia, L.; Wong, H.; Cerna, C.; Weitman, S.D. Pharm. Res., 2002, 19, 1091.
26. Kocbek, P.; Baumgartner, S.; Kristl, J. Int. J. Pharm., 2006, 312, 179.
27. Hecq, J.; Deleers, M.; Fanara, D.; Vranckx, H.; Amighi, K. Int. J. Pharm., 2005, 299, 167.
28. Hecq, J.; Deleers, M.; Fanara, D.; Vranckx, H.; Boulanger, P.; Le Lamer, S.; Amighi, K. Eur. J. Pharm. Biopharm., 2006, 64 (3), 360.
29. Kayser, O.; Olbrich, C.; Yardley, V.; Kiderlen, A.F.; Croft, S.L. Int. J. Pharm., 2003, 254, 73.
30. Vaughn, J.M.; McConville, J.T.; Crisp, M.T.; Johnston, K.P.; Williams, R.O., 3rd. Drug Dev. Ind. Pharm., 2006, 32, 559.
31. Langguth, P.; Hanafy, A.; Frenzel, D.; Grenier, P.; Nhamias, A.; Ohlig, T.; Vergnault, G.; Spahn-Langguth, H. Drug Dev. Ind. Pharm., 2005, 31, 319.
32. Muller, R.H.; Runge, S.; Ravelli, V.; Mehnert, W.; Thunemann, A.F.; Souto, E.B. Int. J. Pharm., 2006, 317, 82.
33. Rapamune® prescribing information, Wyeth Pharmaceuticals, Inc., 2006.
34. Megace® ES Prescribing Information, Par Pharmaceutical Companies, Inc., 2005.
35. Nanoparticle Technology Now Allows TriCor(R) to Be Taken With or Without Food, Abbott Laboratories Press Release, 2004.
36. TriCor® Prescribing Information, Abbott Laboratories, 2004.
37. Wu, Y.; Loper, A.; Landis, E.; Hettrick, L.; Novak, L.; Lynn, K.; Chen, C.; Thompson, K.; Higgins, R.; Batra, U.; Shelukar, S.; Kwei, G.; Storey, D. Int. J. Pharm., 2004, 285, 135.
38. Majumdar, A.K.; Howard, L.; Goldberg, M.R.; Hickey, L.; Constanzer, M.; Rothenberg, P.L.; Crumley, T.M.; Panebianco, D.; Bradstreet, T.E.; Bergman, A.J.; Waldman, S.A.; Greenberg, H.E.; Butler, K.; Knops, A.; De Lepeleire, I.; Michiels, N.; Petty, K.J. J. Clin. Pharmacol., 2006, 46, 291.
39. Mehnert, W.; Mader, K. Adv. Drug Deliv. Rev., 2001, 47, 165.
40. Muller, R.H.; Mehnert, W.; Lucks, J.S.; Schwarz, C.; zur Muhlen, A.; Weynher, H.; Freitas, C. Eur. J. Pharm. Biopharm., 1995, 41, 62.
41. zur Muhlen, A.; Schwarz, C.; Mehnert, W. Eur. J. Pharm. Biopharm, 1998, 45, 149.
42. Venkateswarlu, V.; Manjunath, K. J. Control Release, 2004, 95, 627.
43. Luo, Y.; Chen, D.; Ren, L.; Zhao, X.; Qin. J. J. Control. Release, 2006, 114, 53.
44. Yang, S.; Zhu, J.; Lu, Y.; Liang, B.; Yang, C. Pharm. Res., 1999, 16, 751.
45. Manjunath, K.; Venkateswarlu, V. J. Control. Release, 2005, 107, 215.
46. Hu, L.; Tang, X.; Cui, F. J. Pharm. Pharmacol., 2004, 56, 1527.
47. Bekerman, T.; Golenser, J.; Domb, A. J. Pharm. Sci., 2004, 93, 1264.
48. Gursoy, R.N.; Benita, S. Biomed. Pharmacother., 2004, 58, 173.
49. Pouton, C.W. Eur. J. Pharm. Sci., 2000, 11 (Suppl 2), S93.
50. Taha, E.I.; Al-Saidan, S.; Samy, A.M.; Khan, M.A. Int. J. Pharm., 2004, 285, 109.
51. Taha, E.I.; Samy, A.M.; Kassem, A.A.; Khan, M.A. Pharm. Dev. Technol., 2005, 10, 363.
52. Palamakula, A.; Nutan, M.T.; Khan, M.A. AAPS PharmSciTech, 2004, 5, e66.
53. Mueller, E.A.; Kovarik, J.M.; van Bree, J.B.; Tetzloff, W.; Grevel, J.; Kutz, K. Pharm. Res., 1994, 11, 301.
54. Neoral Prescribing Information, Novartis Pharmaceuticals Corporation, 2005.
55. Vonderscher, J.; Meinzer, A. Transplant. Proc., 1994, 26, 2925.
56. Levy, G.; Rochon, J.; Freeman, D.; Wong, P.Y.; Banks, L.; Roach, C.; Engel, K.; Grant, D. Transplant. Proc., 1994, 26, 2949.
57. Thomas, K.; Koelwel, C.; Machei, U.; Farber, L.; Gopferich, A. Drug Dev. Ind. Pharm., 2005, 31, 357.
58. Kees, F.; Bucher, M.; Schweda, F.; Gschaidmeier, H.; Burhenne, J.; Mikus, G.; Faerber, L. Ther. Drug Monit., 2006, 28, 312.
59. Yang, S.G.; Kim, D.D.; Chung, S.J.; Shim, C.K. Int. J. Clin. Pharmacol. Ther., 2006, 44, 233.
60. Nicolaos, G.; Crauste-Manciet, S.; Farinotti, R.; Brossard, D. Int. J. Pharm., 2003, 263, 165.
61. Wu, W.; Wang, Y.; Que, L. Eur. J. Pharm. Biopharm., 2006, 63, 288.
62. Grove, M.; Mullertz, A.; Nielsen, J.L.; Pedersen, G.P. Eur. J. Pharm. Sci., 2006, 28, 233.
63. Araya, H.; Tomita, M.; Hayashi, M. Drug. Metab. Pharmacokinet., 2005, 20, 257.
64. Veltkamp, S.A.; Thijssen, B.; Garrigue, J.S.; Lambert, G.; Lallemand, F.; Binlich, F.; Huitema, A.D.; Nuijen, B.; Nol, A.; Beijnen, J.H.; Schellens, J.H. Br. J. Cancer, 2006, 95, 729.